U.S. Pharmaceutical Sales - Q3 2012

The following is a list of the top 100 prescribed medicines by U.S. National Sales in Q3 2012. Figures include sales through both retail and hospital channels, listed by drug name and sales value in U.S. dollars.

Last updated: February 2014 (updated quarterly).

Top 100 Drugs for Q3 2012 by Sales

Rank Drug Sales ($000)
1 Nexium
AstraZeneca Pharmaceuticals, LP
2.93% Stats
2 Abilify
Otsuka Pharmaceutical Co., Ltd
1.89% Stats
3 (2) Crestor
AstraZeneca Pharmaceuticals, LP
10.74% Stats
4 (2) Cymbalta
Eli Lilly and Company
9.50% Stats
5 (2) Humira
AbbVie, Inc.
13.45% Stats
6 (2) Advair Diskus
GlaxoSmithKline
2.10% Stats
7 (1) Enbrel
Amgen Inc.
12.51% Stats
8 (2) Remicade
Centocor Ortho Biotech, Inc
2.02% Stats
9 (4) Copaxone
Teva Pharmaceuticals
9.93% Stats
10 (1) Neulasta
Amgen Inc.
-1.17% Stats
11 (1) Rituxan
Genentech, Inc (member of Roche group)
-5.61% Stats
12 (4) Atripla
Gilead Sciences, Inc.
1.34% Stats
13 (2) OxyContin
-0.55% Stats
14 (3) Spiriva
Boehringer Ingelheim Pharmaceuticals, Inc
1.31% Stats
15 (4) Januvia
Merck & Co., Inc.
7.50% Stats
16 (2) Avastin
Genentech, Inc (member of Roche group)
0.41% Stats
17 (7) Lantus
Sanofi (formerly Sanofi Aventis)
4.94% Stats
18 (5) Truvada
Gilead Sciences, Inc.
1.56% Stats
19 (7) Lantus Solostar
Sanofi (formerly Sanofi Aventis)
11.36% Stats
20 (2) Epogen
Amgen Inc.
-5.18% Stats
21 (7) Lyrica
Pfizer Inc
9.94% Stats
22 (9) Celebrex
Pfizer Inc
12.77% Stats
23 (20) Singulair
Merck & Co., Inc.
-62.20% Stats
24 (1) Diovan
Novartis Corporation
-4.29% Stats
25 (9) Gleevec
Novartis Corporation
10.57% Stats
26 (4) Herceptin
Genentech, Inc (member of Roche group)
-0.84% Stats
27 (8) Namenda
Forest Pharmaceuticals, Inc
6.05% Stats
28 (14) Suboxone
Reckitt Benckiser Pharmaceuticals Inc.
14.63% Stats
29 (4) Avonex
Biogen Idec
-5.34% Stats
30 (3) enoxaparin
Generic
-15.96% Stats
31 (6) Lucentis
Genentech, Inc (member of Roche group)
-1.88% Stats
32 escitalopram
Generic
-8.48% Stats
33 (6) OneTouch
3.43% Stats
34 (2) Diovan HCT
Novartis Corporation
-7.39% Stats
35 (3) Vyvanse
Shire US Inc
-2.81% Stats
36 (7) Zetia
Merck & Co., Inc.
7.06% Stats
37 (7) AndroGel
AbbVie, Inc.
6.38% Stats
38 (3) methylphenidate
Generic
0.01% Stats
39 (18) Actos
Takeda Pharmaceuticals U.S.A., Inc
-41.96% Stats
40 (5) Lidoderm
Endo Pharmaceuticals
6.92% Stats
41 (7) TriCor
Abbott Laboratories
6.40% Stats
42 (7) Rebif
8.88% Stats
43 (3) Symbicort
AstraZeneca Pharmaceuticals, LP
4.37% Stats
44 (10) Novolog
Novo Nordisk, Inc.
8.83% Stats
45 (5) Incivek
Vertex Pharmaceuticals
-18.72% Stats
46 (9) Seroquel XR
AstraZeneca Pharmaceuticals, LP
6.05% Stats
47 (3) Alimta
Eli Lilly and Company
-1.39% Stats
48 (8) Viagra
Pfizer Inc
7.82% Stats
49 (8) Levemir
Novo Nordisk, Inc.
7.66% Stats
50 (1) amphetamine/dextroamphetamine
Generic
-0.97% Stats
51 (12) NovoLog FlexPen
Novo Nordisk, Inc.
11.89% Stats
52 (12) ProAir HFA
Teva Pharmaceuticals
12.06% Stats
53 (7) Lovaza
GlaxoSmithKline
8.82% Stats
54 (1) Combivent
Boehringer Ingelheim Pharmaceuticals, Inc
-1.79% Stats
55 (22) Varivax
Merck & Co., Inc.
31.34% Stats
56 (3) Niaspan
Abbott Laboratories
4.70% Stats
57 (10) Procrit
Janssen Pharmaceuticals, Inc
-10.20% Stats
58 (8) Humalog
Eli Lilly and Company
8.03% Stats
59 (1) metoprolol
Generic
-0.87% Stats
60 (2) Neupogen
Amgen Inc.
2.65% Stats
61 (9) Nasonex
Merck & Co., Inc.
-9.30% Stats
62 (1) Flovent HFA
GlaxoSmithKline
-2.46% Stats
63 (2) Reyataz
Bristol-Myers Squibb Company
1.20% Stats
64 (4) Isentress
Merck & Co., Inc.
2.58% Stats
65 (6) Vytorin
Merck & Co., Inc.
6.33% Stats
66 (1) modafinil
Generic
-0.79% Stats
67 (3) Janumet
Merck & Co., Inc.
5.21% Stats
68 (5) Cialis
Eli Lilly and Company
9.05% Stats
69 (14) acetaminophen/hydrocodone
Generic
18.96% Stats
70 (17) Gilenya
Novartis Corporation
21.19% Stats
71 (2) Aranesp
Amgen Inc.
-1.51% Stats
72 (3) Restasis
Allergan, Inc
7.35% Stats
73 (6) Aciphex
Eisai Corporation
10.07% Stats
74 (24) Victoza
Novo Nordisk, Inc.
27.22% Stats
75 (1) Pradaxa
Boehringer Ingelheim Pharmaceuticals, Inc
3.84% Stats
76 (6) Orencia
Bristol-Myers Squibb Company
6.17% Stats
77 (11) Betaseron
Bayer Healthcare Pharmaceuticals
11.98% Stats
78 (49) Eloxatin
Sanofi (formerly Sanofi Aventis)
-55.33% Stats
79 (7) VESIcare
Astellas Pharma US
9.64% Stats
80 (10) Dexilant
Takeda Pharmaceuticals U.S.A., Inc
13.25% Stats
81 (9) Adderall XR
Shire US Inc
-7.81% Stats
82 (4) fentanyl
Generic
-0.39% Stats
83 (3) Prezista
Janssen Pharmaceuticals, Inc
1.17% Stats
84 () Zostavax
Merck & Co., Inc.
Stats
85 (7) Evista
Eli Lilly and Company
9.53% Stats
86 (7) Benicar
Daiichi Sankyo
9.67% Stats
87 () Gardasil
Merck & Co., Inc.
Stats
88 (68) Lipitor
Pfizer Inc
-67.80% Stats
89 (8) budesonide
Generic
-3.36% Stats
90 (7) Synthroid
Abbott Laboratories
12.61% Stats
91 () Xolair
Stats
92 (2) Renvela
Genzyme Corporation
7.39% Stats
93 (4) Lunesta
Sunovion Pharmaceuticals Inc.
2.23% Stats
94 (10) Prevnar 13
Wyeth
-5.86% Stats
95 (1) Xeloda
Roche Pharmaceuticals
5.28% Stats
96 () EpiPen 2-Pak
Stats
97 () Sensipar
Amgen Inc.
Stats
98 (7) Zyvox
Pfizer Inc
-1.37% Stats
99 (85) atorvastatin
Generic
-78.25% Stats
100 () Stelara
Stats

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Hide
(web3)